Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial.

Jones, Alexis; Muller, Patrick; Dore, Caroline J; Ikeji, Felicia; Caverly, Emilia; Chowdhury, Kashfia; Isenberg, David A; Gordon, Caroline; Ehrenstein, Michael R; (2019) Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trial. BMJ OPEN, 9 (12). e032569-. ISSN 2044-6055 DOI: https://doi.org/10.1136/bmjopen-2019-032569

Permanent Identifier

Use this Digital Object Identifier when citing or linking to this resource.

https://doi.org/10.1136/bmjopen-2019-032569

Abstract

Share

Download

Filename: Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol a prospective m.pdf

Licence: Creative Commons: Attribution-Noncommercial-No Derivative Works 3.0

Download
[img]

Downloads

View details

Metrics & Citations


Google Scholar